# Sejong General Hospital

Organization · id `cardio:org-sejong-general-hospital` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ROR record 02t3sfp68](<https://ror.org/02t3sfp68>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 7 trials in this atlas.

## Technical summary

Sponsor class other. Matched to ROR record 02t3sfp68 by an exact name.

## The registry's words

- Sponsor name: Sejong General Hospital
- Sponsor class: OTHER
- ROR name: Sejong General Hospital

## Connected pages

- Sponsors: A Multicenter, Phase 3 Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan(BR-A-657∙K) 30mg Compared to Placebo in Patients With Mild to Moderate Essential Hypertension (`cardio:ct-nct01672476`)
- Sponsors: Efficacy and Safety of Paclitaxel-eluting Balloon for Treatment of Lesions in Native Small Coronary Arteries (`cardio:ct-nct01903902`)
- Sponsors: FFR Versus Angiography-Guided Strategy for Management of AMI With Multivessel Disease (`cardio:ct-nct02715518`)
- Sponsors: Aspirin and a PoTent P2Y12 Inhibitor Versus Aspirin and Clopidogrel in Patients Undergoing PCI for Complex Lesion (`cardio:ct-nct04014803`)
- Sponsors: Long-term Beta-blocker Therapy After Acute Myocardial Infarction (`cardio:ct-nct04769362`)
- Sponsors: Evolocumab in STEMI (`cardio:ct-nct06081803`)
- Sponsors: Comparison of Clopidogrel-based Antiplatelet Agent Treatment and Aspirin Plus Low Dose Rivaroxaban Therapy (`cardio:ct-nct07796217`)

## Provenance

Content hash: 5032dcee6bd2c6e0533625dccc050f4e7212d09781289696c87a8d19cccb76af
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
